Jiaying Yang

Key Laboratory Of Pathobiology
Changchun, 130021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Histone acetyltransferase Kat2a regulates glioma stem cell differentiation via Hsp90aa1-dependent oxidative phosphorylation.

Histone acetyltransferase Kat2a regulates glioma stem cell differentiation via Hsp90aa1-dependent oxidative phosphorylation.

Journal: Biochemical pharmacology

Published: May 16, 2026

Integrated profiling identifies NCOA3 as a prognostic factor in patients with glioma.

Integrated profiling identifies NCOA3 as a prognostic factor in patients with glioma.

Journal: Functional & integrative genomics

Published: April 01, 2026

Taxifolin promotes glioma stem cell differentiation via CYP1B1-mediated EMT suppression.

Taxifolin promotes glioma stem cell differentiation via CYP1B1-mediated EMT suppression.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 09, 2025

Transglutaminase 2 promotes breast cancer cell autophagy by targeting p53/ mTOR axis.

Transglutaminase 2 promotes breast cancer cell autophagy by targeting p53/ mTOR axis.

Journal: Biochemical pharmacology

Published: January 08, 2025

Continuous glucose monitoring (CGM) system based on protein hydrogel anti-biofouling coating for long-term accurate and point-of-care glucose monitoring.

Continuous glucose monitoring (CGM) system based on protein hydrogel anti-biofouling coating for long-term accurate and point-of-care glucose monitoring.

Journal: Biosensors & bioelectronics

Published: December 11, 2024

Is pyroptosis a brake or an accelerator in the fate of the tumor?

Is pyroptosis a brake or an accelerator in the fate of the tumor?

Journal: Cell death & disease

Published: July 20, 2024

Comprehensive gene set enrichment and variation analyses identify SUV39H1 as a potential prognostic biomarker for glioblastoma immunorelevance.

Comprehensive gene set enrichment and variation analyses identify SUV39H1 as a potential prognostic biomarker for glioblastoma immunorelevance.

Journal: Computational and structural biotechnology journal

Published: July 10, 2024

Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.

Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.

Journal: Materials today. Bio

Published: June 28, 2024

Multifunctional nanozymes: Promising applications in clinical diagnosis and cancer treatment.

Multifunctional nanozymes: Promising applications in clinical diagnosis and cancer treatment.

Journal: Biosensors & bioelectronics

Published: March 03, 2024

STING in tumors: a focus on non-innate immune pathways.

STING in tumors: a focus on non-innate immune pathways.

Journal: Frontiers in cell and developmental biology

Published: August 16, 2023

Histone chaperone SSRP1 is required for apoptosis inhibition and mitochondrial function in HCC via transcriptional promotion of TRAP1.

Histone chaperone SSRP1 is required for apoptosis inhibition and mitochondrial function in HCC via transcriptional promotion of TRAP1.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: April 21, 2023

RSL3 triggers glioma stem cell differentiation via the Tgm2/AKT/ID1 signaling axis.

RSL3 triggers glioma stem cell differentiation via the Tgm2/AKT/ID1 signaling axis.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: June 03, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026